More people will have access to a new treatment for Alzheimer’s — thanks to a University of Washington (UW) study called AHEAD.
, is the first traditionally-approved treatment that addresses the underlying biology of Alzheimer’s and changes the course of the disease in a meaningful way for people in the early stages.
“It’s been over 20 years since the last Alzheimer’s drug was approved by the FDA so this is a really exciting moment,” UW Medicine behavioral neurologist Michael Rosenbloom, M.D. told KIRO Newsradio. Lecanemab slowed participants’ cognitive and functional decline by 27% over the course of 18 months during Clarity AD trials, Rosenbloom said, adding that the drug’s longer-term effectiveness is not well understood.
“When you see multiple drugs of the same class meeting the primary outcome measures, this shows that this is not a fluke. We have a real disease-modifying agent that is beneficial for patients,” Rosenbloom said in a prepared statement. “When I became a behavioral neurologist over 13 years ago, the idea of having a disease-modifying drug sounded like science fiction.”The AHEAD study will further measure and monitor the influence of Lecanemab.
“For the first time, we have a drug that is approved for Alzheimer’s disease that is developed to be disease-modifying and actually met its primary outcome measures,” Rosenbloom said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Espresso could lower your risk for Alzheimer’s disease, study findsNew research published Wednesday found that drinking a shot of espresso could lower a person’s risk for Alzheimer’s disease.
Read more »
UW study increases access to expensive Alzheimer’s treatmentMore people will have access to a new treatment for Alzheimer’s — thanks to a UW study
Read more »
Tony Bennett, masterful stylist of American musical standards, dies at 96BREAKING: Publicist Sylvia Weiner confirmed Tony Bennett's death, saying he died in his hometown of New York. There was no specific cause, but Bennett had been diagnosed with Alzheimer's disease in 2016. He was 96.
Read more »
Tony Bennett, Legendary American Singer, Dies at 96BREAKING: Tony Bennett, the acclaimed pop and jazz singer, died on Friday. He was 96.
Read more »
Tony Bennett, masterful stylist of American musical standards, dies at 96Tony Bennett, the eminent and timeless stylist whose knack for creating new standards graced a decadeslong career, died Friday. He was 96.
Read more »
R.I.P. Tony Bennett, prolific singer and showmanAfter living with Alzheimer's for years, Tony Bennett has died at 96
Read more »